Autres langues Formosa Laboratories, Inc.

Actions

4746

TW0004746003

Produits pharmaceutiques

Cours en clôture Taiwan S.E. 08/10/2026			Varia. 5j.	Varia. 1 janv.
48,95 ^TWD	+1,87 %		+1,77 %	-17,45 %

13/08	Formosa Laboratories, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
14/05	Formosa Laboratories, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

13/08	Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
14/05	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
17/03	Formosa Laboratories, Inc. Receives US FDA Approval For Eribulin Injection Under ANDA Pathway
12/03	Formosa Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
12/03	Formosa Laboratories, Inc. announces Annual dividend, payable on September 24, 2026
14/12	Sandoz Receives Complete Response Letter from US FDA, for EG12014 150 mg Lyophilized Powder
13/11	Formosa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Formosa Laboratories Logs NT$30.3 Million Loss in H1
13/08/25	Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
08/05/25	Formosa Laboratories, Inc. Announces Dividend for the Period of January 1, 2024 to December 31, 2024
08/05/25	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
12/03/25	Formosa Laboratories, Inc. Announces Establishment of the GLP-1 Production Line
12/03/25	Formosa Laboratories, Inc. announces Annual dividend, payable on September 25, 2025
12/03/25	Formosa Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
14/11/24	Formosa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
09/08/24	Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
25/07/24	Formosa Laboratories, Inc. Announces Common Stock Dividend Distribution, Payable on September 12, 2024
03/06/24	Formosa Laboratories, Inc. (TWSE : 4746) acquired SynChem, Inc.
15/05/24	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
12/03/24	Formosa Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
12/03/24	Formosa Laboratories, Inc. Approves Dividend Distribution for Full Year Ended December 31, 2023
07/03/24	Japanese Shares Close Lower But Hit Fresh 52-Week High on US Rate Cut Assurance
07/03/24	Sosei Group to Get $2.5 Million Milestone Payment from Formosa Pharmaceuticals
10/11/23	Formosa Laboratories, Inc. Announces Change of Members of the Sustainable Development Committee
10/11/23	Formosa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023